BEST PART(*must read*) In order to clarify the present state of shareholdings in EKO, the company wishes to confirm that it fully complied with the April Order by the Chancery Court of Delaware to issue 2,926,224free trading shares of EKO, bringing the number of issued and outstanding shares as of the date of this release from 28,756,746 to 31,682,970 and the current float of free trading shares as of the date of this release to 8,079,427.
EKO will be issuing a further 1,000,000 restricted shares to NeuroVasc Medical Inc. in consideration for EKO's participation in the NCI Joint venture which holds the exclusive rights to market FREMS equipment.
News 
Market Data 
Discover 
